About Hospital Universitari Germans Trias i Pujol; Servicio de Oncologia
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
3
Genentech, Inc.
1
Clinical Trials at Hospital Universitari Germans Trias i Pujol; Servicio de Oncologia
During the past decade, Hospital Universitari Germans Trias i Pujol; Servicio de Oncologia conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Safety and Efficacy of Carboplatin/Paclitaxel and Carboplatin/Paclitaxel/Bevacizumab With and Without Pictilisib in Previously Untreated Advanced or Recurrent Non-small Cell Lung Cancer
Pertuzumab in Platinum-Resistant Low Human Epidermal Growth Factor Receptor 3 (HER3) Messenger Ribonucleic Acid (mRNA) Epithelial Ovarian Cancer (PENELOPE)
2012-10-22
2016-04-28
Completed
208
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Hospital Universitari Germans Trias i Pujol; Servicio de Oncologia
According to Clinical.Site data, the most researched conditions in "Hospital Universitari Germans Trias i Pujol; Servicio de Oncologia" are
"Glioblastoma" (1 trials), "Malignant Melanoma" (1 trials), "Non-Small Cell Lung Cancer" (1 trials) and "Ovarian Cancer" (1 trials). Many other conditions were trialed in "Hospital Universitari Germans Trias i Pujol; Servicio de Oncologia" in a lesser frequency.
Clinical Trials Intervention Types at Hospital Universitari Germans Trias i Pujol; Servicio de Oncologia
Most popular intervention types in "Hospital Universitari Germans Trias i Pujol; Servicio de Oncologia" are "Drug" (4 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Bevacizumab" (1 trials), "Gemcitabine (Chemotherapy)" (1 trials), "Paclitaxel (Chemotherapy)" (1 trials) and "Pertuzumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Hospital Universitari Germans Trias i Pujol; Servicio de Oncologia
The vast majority of trials in "Hospital Universitari Germans Trias i Pujol; Servicio de Oncologia" are
3 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Hospital Universitari Germans Trias i Pujol; Servicio de Oncologia
Currently, there are NaN active trials in "Hospital Universitari Germans Trias i Pujol; Servicio de Oncologia".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Hospital Universitari Germans Trias i Pujol; Servicio de Oncologia,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Hospital Universitari Germans Trias i Pujol; Servicio de Oncologia, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".
Departments of Hospital Universitari Germans Trias i Pujol; Servicio de Oncologia
Hospital Universitari Germans Trias i Pujol; Servicio de Oncologia has several departments that took part in Clinical trials: "Hospital Germans Trias i Pujol - Hematology" - 2 trials, "Hospital Universitario Germans Trias I Pujol, Servicio de Hematologia" - 2 trials